Trade KOD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Kodiak Sciences Inc (KOD) is trading at US$36.16, down 0.56% today as of Sep 4, 10:31 EDT. The company has a market capitalisation of US$2.41B. Over the past 52 weeks, KOD has traded between US$8.55 and US$47.84. On Syfe you can trade KOD with $0 commission and add it to your watchlist.
| Previous close | US$36.36 |
|---|---|
| Market cap | US$2.41B |
| 52-week range | US$8.55 – US$47.84 |
| Volume | 459.55K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Kodiak Sciences Inc
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Year: 2018
Chardan Upgrades Kodiak Sciences to Buy From Neutral, Raises Price Target to $61 From $14
May 11, 12:54 PM · MT Newswires
Kodiak Sciences Insider Sold Shares Worth $1,197,488, According to a Recent SEC Filing
Apr 6, 8:09 AM · MT Newswires
Sector Update: Health Care Stocks Higher Late Afternoon
Apr 1, 7:57 PM · MT Newswires
Sector Update: Health Care Stocks Advance Wednesday Afternoon
Apr 1, 5:51 PM · MT Newswires
Kodiak Sciences Inc (KOD) stock is trading at US$36.16, -0.56% from the previous close of US$36.36.
The market cap for Kodiak Sciences Inc (KOD) stock is approximately US$2.41B.
The 52-week high for Kodiak Sciences Inc (KOD) stock is US$47.84.
The 52-week low for Kodiak Sciences Inc (KOD) stock is US$8.55.
Kodiak Sciences Inc (KOD) does not currently pay a dividend.
Stay on top of KOD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
